Novartis Leprosy Drug Lamprene To Be Distributed By HHS
Executive Summary
HHS will be the sole distributor for Novartis' leprosy drug Lamprene (clofazimine) beginning this summer
You may also be interested in...
Bristol-Funded Africa HIV/AIDS Research Program Will Treat Subjects For Life
Patients enrolled in clinical trials supported by Bristol-Myers Squibb's "Secure the Future" international HIV/AIDS research and community outreach program will have access to treatment for life.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials